IL1B and metabolic dysfunction-associated steatotic liver disease: Curcumin significantly reduced the levels of IL-1β in NAFLD models [SMD = −2.60, 95% CI (−3.31, −1.90), p < 0.0001] and LF models [n = 52, SMD = −2.72, 95% CI (−3.93, −1.51), p < 0.0001] (Supplementary Figure S4).